Key facts
- Notable investors include Innoangel Fund, Hainan Houshi Private Equity Fund Management, Shicui Capital, Virtue Inno Valley.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Meiaobote
- ·The full record, as it builds
Funding rounds
No funding rounds for Meiaobote are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meiaobote
Developer of microbial engineering and biological technology intended for strengthening agricultural protection and functional myxobacterial resources. The company offers advanced capabilities in microbial strain discovery, selective cultivation, controlled fermentation, biological activity enhancement, and agricultural application refinement, integrating specialized agents that protect crops from persistent plant diseases through natural mechanisms and environmentally aligned microbial performance, enabling growers, researchers, and allied sectors to expand access to green biological innovation.
- Sector
- Materials and Resources
- HQ
- Suzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Meiaobote doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meiaobote shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meiaobote in its N-PORT filings yet. We sweep new filings monthly.